Literature DB >> 678784

Proliferative retinopathy in a patient with diabetes mellitus and idiopathic haemochromatosis.

C H Walsh, J M Malins.   

Abstract

Entities:  

Mesh：

Year:  1978        PMID： 678784      PMCID： PMC1605750          DOI： 10.1136/bmj.2.6129.16-a

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  4 in total

1.  Absence of intercapillary glomerulosclerosis in the diabetic patient with hemochromatosis.

Authors:  P LONERGAN; S L ROBBINS
Journal:  N Engl J Med       Date:  1959-02-19       Impact factor: 91.245

2.  [Protective effects of hemochromatosis against senile and diabetic angiopathies].

Authors:  J Pirart; P Barbier
Journal:  Diabetologia       Date:  1971-08       Impact factor: 10.122

3.  Occurrence and prevalence of diabetic retinopathy in hemochromatosis.

Authors:  J D Griffiths; I W Dymock; E W Davies; D W Hill; R Williams
Journal:  Diabetes       Date:  1971-11       Impact factor: 9.461

4.  Retinopathy and plasma growth hormone levels in idiopathic hemochromatosis with diabetes.

Authors:  P Passa; F Rousselie; C Gauville; J Canivet
Journal:  Diabetes       Date:  1977-02       Impact factor: 9.461
  4 in total
  3 in total

1.  The evolution of diabetic retinopathy.

Authors:  E V Kohner
Journal:  Ir J Med Sci       Date:  1979       Impact factor: 1.568

2.  A hemochromatosis-causing mutation C282Y is a risk factor for proliferative diabetic retinopathy in Caucasians with type 2 diabetes.

Authors:  Borut Peterlin; Mojca Globočnik Petrovič; Jana Makuc; Marko Hawlina; Daniel Petrovič
Journal:  J Hum Genet       Date:  2003-11-15       Impact factor: 3.172

3.  Iron Overload Accelerates the Progression of Diabetic Retinopathy in Association with Increased Retinal Renin Expression.

Authors:  Kapil Chaudhary; Wanwisa Promsote; Sudha Ananth; Rajalakshmi Veeranan-Karmegam; Amany Tawfik; Pachiappan Arjunan; Pamela Martin; Sylvia B Smith; Muthusamy Thangaraju; Oleg Kisselev; Vadivel Ganapathy; Jaya P Gnana-Prakasam
Journal:  Sci Rep       Date:  2018-02-14       Impact factor: 4.379
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.